Ann: Quarterly Update and Appendix 4C, page-4

The opening reads very well:

"Tony Keating, CEO and Managing Director commented on the quarter: “With key regulatory
approvals in Australia and Europe secured, much of the quarter was spent laying the groundwork
for successful commercialisation. We are building a strong commercial pipeline and our
partnership with Coviu represents a major opportunity to integrate our unique technology into
Australia’s largest telehealth platform. We continue to engage with and receive very positive
feedback from hospital emergency departments, telehealth organisations and other healthcare
companies globally; and we expect these discussions to convert into formal agreements in the
coming months. We are also excited by the progress we’ve made with Sanofi on a consumerfacing respiratory disease product during the Startup Creasphere program and are now looking
forward to the next step in that project.”